The GCC intravenous solutions market size reached US$ 701.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 997.8 Million by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028.
Intravenous (IV) solutions refer to a mix of chemically prepared fluids that are administered in the body through venous circulation. They are composed of medications and nutrients such as carbohydrates, amino acids, salts, electrolytes, vitamins, and minerals. IV solutions provide nutrients to patients suffering from cancer, diabetes, immune deficiencies, heart failure and other related diseases. In the GCC region, the demand for intravenous therapy has escalated as it offers rapid onset of drug effects compared to other drug delivery systems.
The GCC intravenous solutions market is primarily driven by the growing cases of gastrointestinal disorders, AIDS, obesity, and diabetes in the region. Apart from this, governments of several GCC countries, like Saudi Arabia, Oman and Qatar, are undertaking initiatives to offer better healthcare facilities to the people, which has increased the demand for IV solutions in the region. Besides this, the introduction of new intravenous solution products for different diseases and the treatment of dehydration is catalyzing the growth of the market. Furthermore, the faster response time and the rapid onset of drugs offered in the IV solution therapy are significant factors contributing to the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the GCC intravenous solutions market report, along with forecasts at the regional and country level from 2023-2028. Our report has categorized the market based on type and nutrients.
Breakup by Type:
Breakup by Nutrients:
- Salts and Electrolytes
- Amino Acids
Breakup by Country:
- Saudi Arabia
The competitive landscape of the industry has also been examined along with the profiles of the key players.
|Base Year of the Analysis
||Type, Nutrients, Country
||Saudi Arabia, UAE, Qatar, Oman, Kuwait, Bahrain
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)